In addition to these malignancies, other cancers were reported to benefit from STAT3 in phenotype and prognosis as well, such as breast cancer [40, 42], head and neck neoplasms [25], and brain tumor [43, 44]. This evidence concerns the gene STAT3 and breast carcinoma.